Diabetes

Information for People on SGLT-2 inhibitors

Sodium glucose co-transporter inhibitors (SGLT-2 inhibitors) are sometimes known as ‘gliflozins’ e.g. canagliflozin (Invokana®), dapagliflozin (Forxiga®), empagliflozin (Jardiance®), ertugliflozin (Steglatro®).

They are prescribed for type 2 diabetes, heart failure (weak pump function of the heart) or kidney disease. They can also be prescribed if you have one or more of these conditions:

Visit
www.maylanesurgery.co.uk/surgery-information/information-for-people-on-sglt-2-inhibitors

Website
www.leedsth.nhs.uk/patients
/resources/information-for-people-on-sglt-2-inhibitors